ClinicalTrials.gg
Status unknownNCT01338766STRiDEUpdated Apr 23, 2014

Spondylolisthesis Treated With an iO-Flex® System Enabled Decompression

An interventional study of Decompression using the iO-Flex® system in Radiculopathy, Spondylolisthesis and Lumbar Spinal Stenosis, sponsored by Baxano Surgical, Inc.. Status unknown at 14 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-04-23.

Sponsored by Baxano Surgical, Inc. · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2014), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the clinical performance of a decompression using the FDA cleared iO-Flex® System on-label in treating patients with spinal stenosis and stable grade I degenerative lumbar spondylolisthesis using a precision estimate assuming a 55% positive response rate.

Read the detailed description

This is a prospective, non-randomized, multi-center (up to 30 sites) controlled clinical study enrolling 100 subjects following a pre-specified protocol with no site enrolling more than 30 subjects. All eligible subjects providing written informed consent and meeting study eligibility criteria will receive a facet preserving decompression using the FDA cleared iO-Flex® system on label. Treatment success using the iO-Flex® System will be analyzed using a precision estimate assuming a 55% positive response rate.

In addition to baseline characteristics and procedural parameters, subject outcomes will be assessed at 6 weeks, 6-, 12-, and 24 months. The study will have an extended follow-up phase with annual follow-up contact through 5 years to evaluate retreatment for the original indication at these late time points.

02

Conditions studied

  • Radiculopathy
  • Spondylolisthesis
  • Lumbar Spinal Stenosis

Keywords

  • spondylolisthesis
  • lumbar spinal stenosis
03

In context

Radiculopathy

483 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 373 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Baxano Surgical, Inc. is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adult (> 18 years of age)
  2. Leg/buttock pain, with or without back pain
  3. Grade 1 degenerative spondylolisthesis (≤25% slippage)
  4. NRS pain score for leg pain of 4/10 or greater
  5. ODI score of 30/100 or greater
  6. Failed non-operative medical management for a period of at least 6 months
  7. Confirmed clinical diagnosis of lumbar spinal stenosis
  8. Confirmation of central and/or lateral recess stenosis with or without foraminal stenosis, at one level or at two adjacent levels from L2-S1, with concordant symptoms. Subjects with central and/or lateral recess stenosis and spondylolisthesis at one level, may have symptomatic central, lateral recess or foraminal stenosis treated at one adjacent level. A "below-the pedicle" pass to decompress a third segment can be completed provided laminotomies are performed at no more than 2 levels. Subjects that, following an intraoperative decision, have a 3-level laminotomy and decompression will not be considered enrolled. Confirmation of spinal stenosis is shown on MRI or CT scan with evidence of nerve root impingement (displacement or compression) by either osseous or non-osseous elements.
  9. Ability to give voluntary, written to participate in this clinical investigation and ability to participate in follow up examinations and complete patient questionnaires

Exclusion criteria

Exclusion Criteria:

  1. Back pain only
  2. Diagnosis of moderate to severe peripheral neuropathy such as diabetic or idiopathic peripheral neuropathy, by EMG/NCS or a Neurologist.
  3. History of pathologic fractures of the vertebrae
  4. Primary disc pathology; planned or incidental discectomies will NOT be excluded as long as surgeon believes the disc pathology is not the primary reason for the surgical intervention.
  5. Subjects for whom removal of the midline structures is planned, likely or is the result of an intraoperative decision; every attempt should be made to spare the supraspinous, interspinous and facet capsular ligaments.
  6. Significant instability of the lumbar spine as defined by ≥ 4mm translational motion between standing lateral view flexion and extension radiographs
  7. Prior surgery of the lumbar spine
  8. Spondylolisthesis greater than grade 1 (on a scale of 1 to 4)
  9. Spondylolysis (pars fracture) at any level in the lumbar spine
  10. Degenerative lumbar scoliosis with a Cobb angle of ≥ 25°
  11. Vascular claudication in the lower extremities
  12. Cauda equina syndrome
  13. Evidence of active (systemic or local) infection at time of surgery
  14. Paget's disease at involved segment or to the vertebra, osteomalacia, or other metabolic bone disease
  15. Tumor in the spine or a malignant tumor except for basal cell carcinoma.
  16. Prisoner or transient
  17. Any significant psychological disturbance past or present, psychotic or neurotic that could impair the consent process or ability to complete subject self-report questionnaires
  18. Involved in pending litigation of the spine or worker's compensation related to the back
  19. Inability to communicate clearly in the English language
  20. Morbid obesity ( > 40)
  21. Pregnant, nursing, or planning on becoming pregnant.
  22. History of narcotic abuse
  23. Current involvement in another drug or device clinical trial
  24. Uncontrolled diabetes
  25. Irreversible coagulopathy or bleeding disorder (patients on anticoagulant therapy may participate. Investigators should follow routine practices for perioperative discontinuation and reinitiation of anticoagulants.)
  26. Plans to relocate in the next 2 years
  27. Subject unwilling to undergo a blood transfusion, if necessary
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Surgery

    Decompression using the iO-Flex® system

    Procedure: Decompression using the iO-Flex® system

Interventions

  • ProcedureDecompression using the iO-Flex® system

    Decompression using the iO-Flex® system

06

What researchers measure

Primary outcomes

  1. Oswestry Disability Index (ODI)

    Responder analysis

    Time frame: 24 Months

Secondary outcomes

  1. Operative success

    Achieving intended decompression using the iO-Flex® System. The number of neural foramen in which the iO-Flex® System was used for decompression compared to the number in which an attempt was made but not completed.

    Time frame: Operative (day 1)

  2. Oswestry Disability Index (ODI)

    Responder analysis

    Time frame: 6, 12, 36, 48 and 60 months

  3. Oswestry Disability Index (ODI)

    Comparison of ODI scores between baseline and each of the following follow-up visits: 6, 12, 24, 36, 48, and 60 month visits

    Time frame: 6, 12, 24, 36, 48 and 60 months

  4. Numerical Rating Scale (NRS)

    Comparison of NRS scores for back and leg pain between baseline and each of the following follow-up visits: 6, 12, 24, 36, 48, and 60 month visits

    Time frame: 6, 12, 24, 36, 48 and 60 months

  5. Zurich Claudication Questionnaire (ZCQ)

    Comparison of ZCQ scores between baseline and each of the following follow-up visits: 6, 12, 24, 36, 48, and 60 month visits

    Time frame: 6, 12, 24, 36, 48 and 60 months

  6. SF-36 Health Survey

    Comparison of SF-36 scores between baseline and each of the following follow-up visits: 6, 12, 24, 36, 48, and 60 month visits

    Time frame: 6, 12, 24, 36, 48 and 60 months

  7. Treatment survival rate

    To characterize longevity of the treatment effect of a decompression using the iO-Flex® System.

    Time frame: Ongoing out to 60 months

07

Study locations

14 sites
  • Eden Medical Center
    Castro Valley, California 94546, United States
  • Olympia Medical Center
    Los Angeles, California 90036, United States
  • Orange County Neurological Associates
    Mission Viejo, California 92691, United States
  • University California Irvine
    Orange, California 92868, United States
  • Southern California Orthopedic Institute
    Van Nuys, California 91405, United States
  • Georgetown University
    Washington, District of Columbia 20057, United States
  • Medical Center of Trinity
    Odessa, Florida 33556, United States
  • Florida Orthopaedic Institute
    Temple Terrace, Florida 33637, United States
  • Resurgens Orthopaedics
    Cumming, Georgia 30041, United States
  • Suburban Orthopedics
    Bartlett, Illinois 60103, United States
  • Indiana Spine Group
    Carmel, Indiana 46032, United States
  • Scott and White Memorial Hospital
    Temple, Texas 76508, United States
  • VCU Medical Center
    Richmond, Virginia 23219, United States
  • Tuckahoe Orthopedics
    Richmond, Virginia 23226, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2011 and a primary completion of Dec 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 18, 2011
First posted
Apr 20, 2011
Start
Apr 2011
Primary completionEst.
Dec 2014
Last update
Apr 23, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01338766
Lead sponsor
Baxano Surgical, Inc.
Responsible party
Sponsor
First posted
Apr 20, 2011
Start date
Apr 2011
Primary completion
Dec 2014 (estimated)
Last update
Apr 23, 2014

Study contacts

Sylvain Palmer, M.D.
principal investigator · Neurological Surgery Medical Associates

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion